| 1:19-cv-00097 | Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al | Apr 29, 2019 |
| 1:19-cv-01863 | Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. | Oct 4, 2019 |
| 1:19-cv-00745 | Pfizer Inc. et al v. Alembic Pharmaceuticals, Inc. et al. | Apr 25, 2019 |
| 1:19-cv-00747 | Pfizer Inc. et al v. Apotex Inc. et al. | Apr 25, 2019 |
| 1:19-cv-00748 | Pfizer Inc. et al. v. Aurobindo Pharma, Ltd. et al. | Apr 25, 2019 |
| 1:19-cv-00749 | Pfizer Inc. et al. v. Cipla USA Inc. et al. | Apr 25, 2019 |
| 1:19-cv-00750 | Pfizer Inc. et al. v. Dr. Reddy's Laboratories, Inc. et al. | Apr 25, 2019 |
| 1:19-cv-00751 | Pfizer Inc. et al. v. Hetero USA, Inc. et al. | Apr 25, 2019 |
| 1:19-cv-00752 | Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al | Apr 25, 2019 |
| 1:19-cv-00753 | Pfizer Inc. et al v. Natco Pharma, Inc. et al | Apr 25, 2019 |
| 1:19-cv-00754 | Pfizer Inc. et al v. Qilu Pharma, Inc. et al | Apr 25, 2019 |
| 1:19-cv-00758 | Pfizer Inc. et al v. Sun Pharmaceutical Industries, Ltd. et al | Apr 25, 2019 |
| 1:19-cv-00759 | Pfizer Inc. et al v. Teva Pharmaceuticals USA, Inc. et al | Apr 25, 2019 |
| 1:19-cv-00760 | Pfizer Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al | Apr 25, 2019 |
| 1:19-cv-11737 | PFIZER INC. et al v. AIZANT DRUG RESEARCH SOLUTIONS PVT. LTD. et al | Apr 29, 2019 |
| 1:19-cv-11742 | PFIZER INC. et al v. DR. REDDY'S LABORATORIES, INC. et al | Apr 29, 2019 |
| 1:19-cv-11746 | PFIZER INC. et al v. SUN PHARMA GLOBAL FZE et al | Apr 29, 2019 |
| 1:19-cv-11748 | PFIZER INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al | Apr 29, 2019 |
| 2:19-cv-01846 | PFIZER, INC. et al v. QILU PHARMA, INC. et al | Apr 29, 2019 |
| 1:19-md-02912 | In re: Palbociclib Patent Litigation | Oct 2, 2019 |
| 1:21-cv-00284 | Pfizer Inc. et al v. Synthon Pharmaceuticals, Inc. et al | Feb 24, 2021 |
| 1:21-cv-00157 | PFIZER INC. et al v. SYNTHON PHARMACEUTICALS, INC. et al | Feb 25, 2021 |
| 1:21-cv-01179 | Pfizer Inc. et al v. Natco Pharma, Inc. et al | Aug 16, 2021 |
| 1:21-cv-01567 | Pfizer Inc. et al v. Synthon Pharmaceuticals Inc. et al | Nov 3, 2021 |
